Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811310) titled 'Effect of Holy Basil on Subjects With Sensitive Skin' on Sept. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Laboratoires Expanscience S.A.
Condition:
Sensitive Skin Related to Stress
Intervention:
Dietary Supplement: Holy basil extract
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: August 31, 2026
Target Sample Size: 200
Countries of Recruitment:
Spain
To know more, visit https://clinicaltrials.gov/study/NCT07...